FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

8689007: Kanamycin sulfate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
15335018 Kanamycin sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
507301015 Kanamycin sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
829249014 Kanamycin sulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4417631000241119 sulfate de kanamycine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kanamycin sulfate Is a Product containing kanamycin (medicinal product) false Inferred relationship Some
Kanamycin sulfate Is a Bactericide false Inferred relationship Some
Kanamycin sulfate Is a Kanamycin (substance) false Inferred relationship Some
Kanamycin sulfate Is a Substance with aminoglycoside structure and antibacterial mechanism of action (substance) true Inferred relationship Some
Kanamycin sulfate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Kanamycin (substance) true Inferred relationship Some
Kanamycin sulfate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Kanamycin sulfate 75mg/2mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Kanamycin sulfate Inferred relationship Some
Kanamycin sulfate 500mg/2mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Kanamycin sulfate Inferred relationship Some
Product containing precisely kanamycin sulfate 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Kanamycin sulfate Inferred relationship Some
Kanamycin sulfate 1g/vial injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Kanamycin sulfate Inferred relationship Some
Kanamycin sulfate 1g/3mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Kanamycin sulfate Inferred relationship Some
Product containing precisely kanamycin sulfate 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Kanamycin sulfate Inferred relationship Some 1
Product containing precisely kanamycin sulfate 500 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Kanamycin sulfate Inferred relationship Some 1
Product containing precisely kanamycin sulfate 500 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Kanamycin sulfate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start